Search results
The Most Common COVID Symptoms Doctors Are Seeing This Spring
HuffPost Life via Yahoo News· 4 days ago“Those over the age of 60, those with other respiratory conditions like emphysema and COPD, people...
How diagnosing and treating asthma, COPD early can significantly improve quality of life
MedicalNewsToday via AOL· 4 days agoResearchers say a clinical trial has shown how important it is to diagnose asthma and COPD early to...
HealthWell Foundation Opens Fund to Assist Medicare Patients Living with COPD
WTNH-TV New Haven· 1 day agoThe HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for underinsured Americans, announced today it has opened a new fund to provide ...
Community Outreach Identifies Asthma, COPD
Medscape· 3 days agoPersons with asthma or COPD found through community outreach had improvements in lung function and quality of life over 1 year in a randomized trial.
Asthma, COPD often not diagnosed, study indicates
UPI· 5 days agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2...
Medical Xpress· 4 days agoThe disease improvements—as measured by a significantly lower annualized rate of acute exacerbations...
Lung Cancer Screening IDs Pulmonary Comorbidities
Medscape· 1 day agoA majority of individuals with no reported history of COPD showed evidence of COPD symptoms.
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at...
Benzinga· 4 days agoDupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly
Finding Undiagnosed Asthma, COPD and Treating It Shows Benefit in Trial
MedPage Today· 4 days agoIdentifying symptomatic individuals in the community with undiagnosed asthma and chronic obstructive...
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
WTNH-TV New Haven· 5 days agoAmgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive ...